Arena Pharmaceuticals Inc (ARNA) Return on Investment ROI from the fourth quarter of 2021 to fourth quarter of 2019 and for the year 2021, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Arena Pharmaceuticals Inc   (NASDAQ: ARNA)


Arena Pharmaceuticals Inc's ROI from its fourth quarter of 2021 to the fourth quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Arena Pharmaceuticals Inc's ROI in the fourth quarter of 2021?
Arena Pharmaceuticals Inc recorded a cumulative net loss of $-616 million during 12 months ending in the fourth quarter of 2021, resulting in a negative return on investment (ROI) of -69.07%.

Within the Healthcare sector 902 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2021 from 0 to 5269.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Investment Change TTM -21.16 % -11.96 % -3.27 % 3.86 % -3.68 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 682 810 981 1,096 1,091
Return On Investment (TTM) -69.07 % -58.61 % -44.51 % -36.59 % -35.76 %
ARNA's Overall Ranking # 5269 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -10.28 % -8.53 % -5.91 % 2.12 % 0.17 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -616 -583 -484 -423 -405

ARNA Company Profile >> Back to ARNA Roi Comparisons >> See Annual ARNA Return On Investment



Return On Investment ARNA's Ranking
Within: No.
Industry # 439
Sector # 903
Overall # 5269

Return On Investment Statistics
High Average Low
78.82 %
-10.84 %
-66.24 %
(Mar 31 2019)   (Dec 31 2021)







Financial Statements
Arena Pharmaceuticals Inc's IV. Quarter Investments $ 682 Millions ARNA's Balance sheet
Arena Pharmaceuticals Inc's IV. Quarter Income $ -156 Millions Quarterly ARNA's Income Statement
ARNA's Income by Division See ARNA's Income by Division


ARNA Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 682 1,091 608 209 44
Y / Y Investment Growth -37.49 % 79.64 % 190.42 % 376.82 % -69.02 %
Net Income in Millions -616 -405 -29 -93 -23
Y / Y Net Income Growth - - - - -
Annual Return On Investment -90.36 % -37.08 % -4.84 % -44.33 % -52.19 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ARNA's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ARNA's Competitors
Subscribers only: Roi for Arena Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for ARNA's Customers

Other Ratios
ARNA's Roa ARNA's Inventory Turnover Ratio ARNA's Growth Rates ARNA's Dividend Statistics
ARNA's Profitability Ratios ARNA's Asset Turnover Ratio ARNA's Dividend Growth
ARNA's Roe ARNA's Valuation Ratios ARNA's Financial Strength Ratios ARNA's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.